门静脉血栓介入治疗研究进展

doi:10.3969/j.issn.1672-5069.2019.06.003

实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (6): 768-769.doi: 10.3969/j.issn.1672-5069.2019.06.003

门静脉血栓介入治疗研究进展

鲍应军, 任伟新

830054 乌鲁木齐市新疆医科大学第一附属医院介入治疗中心

出版日期:2019-11-13 发布日期:2019-11-13
通讯作者: 任伟新,E-mail:rwx1031@163.com
作者简介:鲍应军,男,32岁,硕士研究生。主要从事外周介入诊断与治疗学研究。E-mail:baodazi@126.com

Interventional therapy for patients with portal vein thrombosis

Bao Yingjun, Ren Weixin.

Interventional Therapy Centre, First Affiliated Hospital, Xinjiang Medical University, Urumqi 830054Ywzy

Online:2019-11-13 Published:2019-11-13

摘要/Abstract

关键词: 门静脉血栓, 介入治疗, 经颈静脉肝内门腔静脉分流术

Key words: Portal vein thrombosis, Interventional therapy, TIPS

鲍应军, 任伟新. 门静脉血栓介入治疗研究进展[J]. 实用肝脏病杂志, 2019, 22(6): 768-769.

Bao Yingjun, Ren Weixin.. Interventional therapy for patients with portal vein thrombosis[J]. Journal of Practical Hepatology, 2019, 22(6): 768-769.

[1] Chawla YK,Bodh V.Portal vein thrombosis. J Clin Exp Hepatol, 2015,32(5):22-40.
[2] Tripodi A,Anstee QM,Sogaard KK,et al.Hypercoagulability in cirrhosis:causes and consequences. J Thromb Haemost,2011,9:1713-1723.
[3] Okuda K,Ohnishi K,Kimura K,et al.Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology,1985,89:279-286.
[4] Amitrano L,Guardascione MA,Brancaccio V,et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol, 2004,40:736-741.
[5] Tsochatzis EA,Senzolo M,Germani G,et al.Portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther,2010,31:366-374.
[6] Mantaka A,Augoustaki A,Kouroumalis EA,et al.Portal vein thrombosis in cirrhosis:diagnosis,natural history,and therapeutic challenges. Ann Gastroenterol,2018,31: 315-329.
[7] Loffredo L,Pastori D,Farcomeni A,et al.Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis:a systematic review and meta-analysis. Gastroenterology,2017,153:480-487.
[8] von Kockritz1 L,de Gottardi1 A,Trebicka J,et al. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep,2017,5(2):148-156.
[9] de Franchis R,Baveno VI Faculty. Expanding consensus in portal hypertension:report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol,2015,63:743-752.
[10] Rossle M.TIPS: 25 years later. J Hepatol,2013,59:1081-1093.
[11] Han G,Qi X,He C,et al.Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol, 2011,54:78-88.
[12] Luca A,Miraglia R,Caruso S, et al.Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut, 2011,60:846-852.
[13] Primignani M,Tosetti G, La Mura V.Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis. World J Hepatol, 2015,7:2906-2912.
[14] Perarnau JM, Baju A,D’alteroche L,et al.Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol,2010,22:1093-1098.
[15] 刘凤永,王茂强,王志强,等.介入治疗门静脉-肠系膜上静脉广泛血栓形成1例.中华肝胆外科杂志,2013,9(10):598-610.
[16] Francoz C,Valla D,Durand F.Portal vein thrombosis,cirrhosis,and liver transplantation. J Hepatol,2012,57:203-212.

门静脉血栓介入治疗研究进展

Interventional therapy for patients with portal vein thrombosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈帅, 杨长青. 门静脉血栓病因及危险因素研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 761-764.
[2]	庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.
[3]	何志安, 余丽萍, 赖江琼, 黄思付. ARFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 888-891.
[4]	徐祺林, 郝少欢, 冉博. 肝硬化脾切除术后门静脉系统血栓形成的危险因素分析*[J]. 实用肝脏病杂志, 2019, 22(5): 708-711.
[5]	黄志寅, 李静. 肝硬化脾切除术利弊权衡细思量[J]. 实用肝脏病杂志, 2019, 22(4): 459-461.
[6]	刘彦君, 李光明. 肝硬化并发门静脉血栓防治研究进展[J]. 实用肝脏病杂志, 2019, 22(4): 605-608.
[7]	肖科, 潘志华, 涂波, 陈丽. 术前CT/MRI检查指标对肝硬化脾切除术后门静脉血栓形成的预测价值[J]. 实用肝脏病杂志, 2019, 22(3): 417-420.
[8]	赵晓飞,林栋栋,李宁,臧运金,郭庆良,武聚山. 脾切除联合食管胃底曲张静脉断流术后应用华法林对门静脉血栓的防治作用[J]. 实用肝脏病杂志, 2019, 22(2): 240-243.
[9]	邱婷, 金燕, 吕颐菲, 王雪, 阎春英. 肝硬化并发门静脉血栓危险因素的Logistic回归分析[J]. 实用肝脏病杂志, 2018, 21(6): 916-919.
[10]	游玉峰, 谭必勇, 何小俊, 胡红耀. PTIPS治疗脾切除术后并发门静脉血栓形成的门静脉高压症患者安全性和效果分析*[J]. 实用肝脏病杂志, 2018, 21(3): 372-375.
[11]	李相文，涂明利. 早期应用低分子肝素预防腹腔镜脾切除食管胃底静脉断流术后门静脉血栓形成临床研究*[J]. 实用肝脏病杂志, 2017, 20(2): 179-182.
[12]	余炎，吕君，余祖江，阚全程. 四种影像学检查评价原发性肝癌患者介入治疗的疗效[J]. 实用肝脏病杂志, 2017, 20(2): 199-202.
[13]	石青, 郭武华. 介入治疗肝硬化门脉高压症并发食管胃底静脉曲张破裂出血研究进展^*[J]. 实用肝脏病杂志, 2016, 19(5): 519-523.
[14]	陆申新综述，陈世耀审校. 抗凝治疗肝硬化患者并发门静脉血栓的循证医学证据*[J]. 实用肝脏病杂志, 2016, 19(5): 624-628.
[15]	陈东风, 孙文静. 原发性肝癌血管性介入治疗的现状[J]. 实用肝脏病杂志, 2015, 18(3): 225-227.